Skip to contentB
Bausch Health Companies Inc.
B
BHCBausch Health Companies Inc. Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.56B$2.56Bderived+6.3% vs Q4 2023 Net Income$93.00M$93.00MderivedN/M vs Q4 2023 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bausch Health Companies Inc. · CIK 885590 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived$558,000,000+54.1% Operating Cash Flowderived$601,000,000+54.1% Free Cash Flowderived$495,000,000+69.5% Margins · derivedOperating margin21.8%+6.8 pt vs Q4 2023
Net margin3.6%+5.3 pt vs Q4 2023
ended Dec 31, 2024 · filed Feb 20, 2025 · 51 d after period end